Availability of diclofenac as a pharmacy medicine (MLX 382)
The MHRA is undertaking a public consultation on the continued availability of diclofenac as a Pharmacy (P) medicine.
Detail
The MHRA is undertaking a public consultation on the continued availability of diclofenac as a Pharmacy (P) medicine and in particular on risk minimisation measures advised by the Commission on Human Medicines.
Comments must arrive no later than 28 October 2013. Comments received after this date will not be taken into account.
Documents